RT Journal Article
SR Electronic
T1 The impact of the new Dutch guideline on cardiovascular risk management in patients with COPD: a retrospective study
JF BJGP Open
JO BJGP Open
FD Royal College of General Practitioners
SP bjgpopen20X101139
DO 10.3399/bjgpopen20X101139
VO 5
IS 1
A1 Lonneke ME Nies
A1 Ingrid Looijmans-van den Akker
A1 Liesbeth Rozendaal
A1 Brenda Baar
A1 Rimke C Vos
A1 Huberta E Hart
YR 2021
UL http://bjgpopen.org/content/5/1/bjgpopen20X101139.abstract
AB Background Patients with chronic obstructive pulmonary disease (COPD) have an independent increased risk of cardiovascular (CV) disease. Cardiovascular risk (CVR) assessment should be offered to all patients with COPD, according to the new Dutch CVR management (CVRM) guideline (May 2019).Aim To evaluate the impact of the new CVRM guideline on the care of patients with COPD in primary care.Design & setting A retrospective study took place within five primary healthcare centres located in The Netherlands.Method In accordance with the guideline, the CVR of all patients with COPD was estimated and categorised. Data from 2014–2019 were used for the qualitative risk assessment based on comorbidities, and the quantitative Systematic Coronary Risk Evaluation (SCORE). In addition, the guideline-based follow-up was investigated.Results Of the 391 patients with COPD, 84.1% (n = 329) had complete data on CVR assessment: 90.3% (n = 297) had a (very) high risk, and 9.7% (n = 32) a low-to-moderate risk. Of the patients with (very) high risk, 73.4% (n = 218) received guideline-based follow-up (primary care: 95.4%, secondary care: 4.6%). In 15.9% (n = 62) of all patients with COPD, the CVR profile was not measured and of the (very) high-risk patients, 26.6% (n = 79) were not enroled in a CV care programme.Conclusion Whereas in the majority of patients with COPD the CVR is already known, for one out of six patients this CVR still has to be assessed according to the recently updated guideline. Moreover, once a (very) high risk has been assessed, as a consequence CV treatment of risk factors should be intensified in one out of four patients with COPD. Adherence to the new CVRM guideline could provide improvement in CVRM in more than a third of all patients with COPD.